Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
COMPARISON OF BASAL INSULIN ADDED TO ORAL AGENTS VERSUS TWICE – DAILY PREMIXED INSULIN AS INITIAL INSULIN THERAPY FOR TYPE 2 DIABETES
COMPARISON OF BASAL INSULIN ADDED TO ORAL AGENTS VERSUS TWICE – DAILY PREMIXED INSULIN AS INITIAL INSULIN THERAPY FOR TYPE 2 DIABETES
Subject
:
Endocrinology
Document Language
:
English
Abstract
:
Objective: To compare the efficacy and safety of adding once – daily basal Glargine insulin versus switching to twice – daily premixed insulin in Type-II diabetic patients not well controlled by combined oral antidiabetic agents. Methods: In a 6 months parallel group clinical trail on 221 patients with Type-II diabetes and poorly controlled on oral antidiabetic agents (fasting blood glucose > 140 mg/ dl and glycosylated hemoglobin >8%) on oral antidiabetic treatment (metformin plus sulfonylurea) were randomized either to add Glargine insulin or to shift them to mixed insulin (30% regular insulin and 70% NPH) twice per day without oral antidiabetic treatment. Insulin dosage was titrated to target fasting blood glucose < 100 mg/dl and predinner blood glucose < 120 mg /dl. Results: Mean hemoglobin A1C decrease from baseline was significantly pronounced (- 2.1 vs. - 1.3 % p = <0.005), and more patients reached HbA1C <7% (57 vs. 31%) with Glargine insulin plus oral antidiabetic treatment than with mixed insulin. The number of patients who achieved the target of fasting blood glucose < 100 mg/dl were more in the group which received Glargine insulin than the other group that received mixed insulin (41.7 vs. 17.8 %). Conclusions: Initiation of insulin therapy in patients with Type-II diabetes uncontrolled on combined metformin and sulfonylurea by adding Glargine insulin was more effective than starting with twice daily of mixed insulin (30% regular insulin and 70% NPH insulin).
ISSN
:
1681-715X
Journal Name
:
Pakistan Journal of Medical Sciences
Volume
:
22
Issue Number
:
1
Publishing Year
:
1426 AH
2006 AD
Article Type
:
Article
Added Date
:
Thursday, October 15, 2009
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
عبدالرحمن الشيخ
Al-Shaikh, AbdulRahman
Researcher
Doctorate
Files
File Name
Type
Description
29163.pdf
pdf
Back To Researches Page